Parkinson's Disease
- 8 October 1998
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 339 (15), 1044-1053
- https://doi.org/10.1056/nejm199810083391506
Abstract
More than 180 years ago, James Parkinson first described the disorder that bears his name, and 30 years ago levodopa, still the most effective therapy, was introduced. Parkinson's disease is a neurodegenerative disorder of unknown cause that affects over 1 million people in North America. Age is the single most consistent risk factor, and with the increasing age of the general population, the prevalence of Parkinson's disease will rise steadily in the future. The impact of the disease is indicated by the fact that mortality is two to five times as high among affected persons as among age-matched controls,1– . . .Keywords
This publication has 81 references indexed in Scilit:
- Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy.Archives of Neurology, 1997
- Mortality From Parkinson DiseaseArchives of Neurology, 1997
- Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Epidemiologic observations on Parkinson's diseaseNeurology, 1996
- Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older PeopleThe New England Journal of Medicine, 1996
- Clinical features and natural history of multiple system atrophyBrain, 1994
- Projected Neurodegenerative Disease Mortality in the United States, 1990–2040Neuroepidemiology, 1993
- A Clinicopathologic Study of 100 Cases of Parkinson's DiseaseArchives of Neurology, 1993
- Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective StudyCanadian Journal of Neurological Sciences, 1991
- Hemiparkinsonism‐hemiatrophy syndromeNeurology, 1990